ClinicaliQ Trial Snapshot
- Novel Technologies for Respiratory Virus Identification — Recruiting • Respiratory / COPD / Asthma • NCT05661032.
- What is being tested: Novel diagnostic technologies designed to improve the speed and accuracy of identifying respiratory viruses, addressing limitations of current detection methods that may be slow, expensive, or have variable sensitivity and specificity.
- Patient eligibility overview: This proof-of-concept study targets patients with suspected respiratory virus infections who require diagnostic testing; specific inclusion/exclusion criteria would be detailed in the full protocol but typically include those presenting with respiratory symptoms.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Current virus detection methods often take significant time or can be limited in sensitivity, specificity or cost. There is therefore a need for diagnostic methods that are simple to use, sensitive, rapid and inexpensive. This is a proof of concept study to determine whether the Pictura Bio system (a new a rapid pathogen identification technology) is able to detect and differentiate different viruses from nasopharyngeal swabs/aspirate specimens. The data collected will be used to "train" the algorithms to be able to accurately identify respiratory viruses. The accuracy with which the…
Eligibility Snapshot
- : * Provide informed, (parental/guardian, where appropriate) consent * Able to provide nasopharyngeal swab/aspirate specimens. * A clinical suspicion of a respiratory viral infection with one or more of the following symptoms: * Coryzal symptoms (runny nose, sneezing and/or nasal congestion) * New onset of cough * Sore throat * Head and/or Muscle aches * Fever or chills
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.